Structure-activity relationships of non-imidazole H3 receptor ligands.: Part 1

被引:25
作者
Faghih, R [1 ]
Dwight, W [1 ]
Gentles, R [1 ]
Phelan, K [1 ]
Esbenshade, TA [1 ]
Ireland, L [1 ]
Miller, TR [1 ]
Kang, CH [1 ]
Fox, GB [1 ]
Gopalakrishnan, SM [1 ]
Hancock, AA [1 ]
Bennani, YL [1 ]
机构
[1] Abbott Labs, Global Pharmaceut Res & Dev, Neurosci Res, Abbott Pk, IL 60064 USA
关键词
D O I
10.1016/S0960-894X(02)00309-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
SAR studies for novel non-imidazole containing H-3 receptor antagonists with high potency and selectivity for rat H-3 receptors are described. A high throughput screening lead, A-923, was further elaborated in a systematic manner to clarify a pharmacophore for this class of aryloxyalkyl piperazine based compounds. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2031 / 2034
页数:4
相关论文
共 23 条
[11]  
LEURS R, 1998, HISTAMINE H3 RECEPTO
[12]  
Ligneau X, 1998, J PHARMACOL EXP THER, V287, P658
[13]   Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H3 receptor antagonists [J].
Linney, ID ;
Buck, IM ;
Harper, EA ;
Kalindjian, SB ;
Pether, MJ ;
Shankley, NP ;
Watt, GF ;
Wright, PT .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (12) :2362-2370
[14]   Cloning and functional expression of the human histamine H3 receptor [J].
Lovenberg, TW ;
Roland, BL ;
Wilson, SJ ;
Jiang, XX ;
Pyati, J ;
Huvar, A ;
Jackson, MR ;
Erlander, MG .
MOLECULAR PHARMACOLOGY, 1999, 55 (06) :1101-1107
[15]   Influence of imidazole replacement in different structural classes of histamine H3-receptor antagonists [J].
Meier, G ;
Apelt, J ;
Reichert, U ;
Grassmann, S ;
Ligneau, X ;
Elz, S ;
Leurquin, F ;
Ganellin, CR ;
Schwartz, JC ;
Schunack, W ;
Stark, H .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (03) :249-259
[16]   Central histaminergic system and cognition [J].
Passani, MB ;
Bacciottini, L ;
Mannaioni, PF ;
Blandina, P .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2000, 24 (01) :107-113
[17]  
Singh J, 2000, J PRAK CHEM-CHEM ZTG, V342, P340, DOI 10.1002/(SICI)1521-3897(200004)342:4<340::AID-PRAC340>3.0.CO
[18]  
2-1
[19]  
Stark H, 2001, PROGR MED CHEM, V38, P279, DOI 10.1016/S0079-6468(08)70096-1
[20]   Novel histamine H3-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds [J].
Stark, H ;
Sadek, B ;
Krause, M ;
Hüls, A ;
Ligneau, X ;
Ganellin, CR ;
Arrang, JM ;
Schwartz, JC ;
Schunack, W .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (21) :3987-3994